2Fodor L,Reeve-Johnson L,Hodge A,et al.Efficacy evaluations of the use of oral tilmicosin in pneumonic calves[J].Vet J,2000,159:194-200.
3Naccari F,Giofre F,Pellegrino M,et al.Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep[J].Vet Rec,2001,148:773-776.
7Cao X Y,Dong M,Shen J Z,et al.Tilmicosin and tylosin have anti-inflammatory properties via modulation of COX-2 and iNOS gene expression and production of cytokines in LPS-induced macrophages and monocytes[J].Antimicrobial Agents,2006,27:431-438.
8Kohri K,Tamaoki J,Kondo M,et al.Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages[J].Eur Respir J,2000,15:62-67.
9Lakritz J,Tyler J W,Marsh A E,et al.Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases[J].Vet Ther,2002,(3):7-21.
6Stephens C P,Blackall P J,Wade L K,et al.In-vitro antibacterial properties of tilmicosin against Australian isolate of Pasteurella multocida and Pasteurella haemolytica from cattle [J].Australian Veterinary Journal, 1993,70(10) :391-392.
7Blackall P J,Asakawa T,Graydon R J,et al. In-vitro antibacterial properties of tilmicosin against Australian isolate of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs [J].Australian Veterinary Journal,1995,72 ( 1 ): 35-36.
8Jordan F T W,Forrester C A,Hodge A,et al.The comparison of an aqueous preparation of tilmicosin with tylosin in the treatment of Mycoplasna gallisepticum infection of turkey poults [J].Avian Diseases, 1999,43 ( 3 ): 521-525.
